T Cell-dependent and -independent IgA responses: Role of TLR signalling

Immunological Investigations

Volumn 39, Issue 4-5, 2010, Pages 407-428

  Bessa, Juliana ^a   Bachmann, Martin F ^a  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

IgA; Mucosa; Toll like receptor; Vaccination

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; ESCHERICHIA COLI ENDOTOXIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; NASALFLU; ORAL POLIOMYELITIS VACCINE; PHOSPHORYL LIPID A; POLYINOSINIC POLYCYTIDYLIC ACID; ROTAVIRUS VACCINE; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

BELL PALSY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE REARRANGEMENT; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFECTION PREVENTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VACCINATION; VIRUS LIKE AGENT;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; INFECTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 77952198029     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820131003663357     Document Type: Review

References (106)

1. Agol, V. I. (2006). Vaccine-derived polioviruses. Biologicals 34:103-108
2. Asahi-Ozaki, Y., Itamura, S., Ichinohe, T., Strong, P., Tamura, S., Takahashi, H. Sawa, H., Moriyama, M., Tashiro, M., Sata, T., Kurata, T., Hasegawa, H. (2006). Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Microbes Infect 8:2706-2714
3. Bachmann, M. F., Kopf, M. (1999). The role of B cells in acute and chronic infections. Curr. Opin. Immunol. 11:332-339
4. Bachmann, M. F., Zinkernagel, R. M. (1997). Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235-270
5. Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., Persing, D. (2004). Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4:1129-1138
6. Barr, T. A., Brown, S., Mastroeni, P., Gray, D. (2009). B Cell intrinsic MyD88 signals drive IFN-{gamma} production from T cells and control switching to IgG2c. J. Immunol. 183:1005-1012
7. Bessa, J., Jegerlehner, A., Hinton, H. J., Pumpens, P. Saudan, P. Schneider, P., Bachmann, M. F. 2009. Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. J. Immunol. 183:3788-3799
8. Bessa, J., Schmitz, N., Hinton, H. J., Schwarz, K., Jegerlehner, A., Bachmann, M. F. (2008). Efficient induction of mucosal and systemic immune responses by viruslike particles administered intranasally: implications for vaccine design. Eur. J. Immunol. 38:114-126
9. Borsutzky, S., Cazac, B. B., Roes, J. Guzman, C. A. (2004). TGF-beta receptor signaling is critical for mucosal IgA responses. J. Immunol. 173:3305-3309
10. Borsutzky, S., Fiorelli, V., Ebensen, T., Tripiciano, A., Rharbaoui, F., Scoglio, A., Link, C., Nappi, F., Morr, M., Butto, S., Cafaro, A., Muhlradt, P. F., Ensoli, B., Guzman, C. A. (2003). Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur. J. Immunol. 33:1548-1556
11. Borsutzky, S., Kretschmer, K., Becker, P. D., Muhlradt, P. F., Kirschning, C. J., Weiss, S., Guzman, C. A. (2005). The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J. Immunol. 174:6308-6313
12. Bossen, C., Cachero, T. G., Tardivel, A., Ingold, K., Willen, L., Dobles, M., Scott, M. L., Maquelin, A., Belnoue, E., Siegrist, C. A., Chevrier, S., Acha-Orbea, H. Leung, H., Mackay, F., Tschopp, J., Schneider, P. (2008). TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111:1004-1012
13. Brandtzaeg, P. (2006). Induction of secretory immunity and memory at mucosal surfaces. Vaccine 30:5467-5484
14. Brandtzaeg, P., Johansen. F.E. (2005). Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206:32-63.
15. Castigli, E., Scott, S., Dedeoglu, F., Bryce, P., Jabara, H., Bhan, A. K., Mizoguchi, E., Geha, R. S. (2004). Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 101:3903-3908
16. Castigli, E., Wilson, S. A., Elkhal, A., Ozcan, E., Garibyan, L., Geha, R. S. (2007). Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J. Allergy Clin. Immunol. 120:885-891
17. Castigli, E., Wilson, S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K. P., Bram, R. J., Jabara, H., Geha, R. S. (2005). TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201:35-39
18. Cazac, B. B., Roes, J. (2000). TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13:443-451
19. Cerutti, A. (2008). The regulation of IgA class switching. Nat. Rev. Immunol. 8:421-434
20. Cerutti, A., Rescigno, M. (2008). The biology of intestinal immunoglobulin A responses. Immunity 28:740-750
21. Chaudhuri, J., Alt, F. W. (2004). Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4:541-552
22. Chen, S. S., Li. Q. (1990). Transforming growth factor-beta 1 (TGF-beta 1) is a bifunctional immune regulator for mucosal IgA responses. Cell Immunol. 128:353-361
23. Cielens, I., Ose, V., Petrovskis, I., Strelnikova, A., Renhofa, R., Kozlovska, T., Pumpens, P. (2000). Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods. FEBS Lett. 482:261-264
24. Clements, M. L., Murphy, B. R. (1986). Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23:66-72.
25. Coates, T., Wilson, R., Patrick, G., Andre, F., Watson, V. (2001). Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin. Ther. 23:392-403.
26. Crouch, E. E., Li, Z., Takizawa, M., Fichtner-Feigl, S., Gourzi, P., Montano, C., Feigenbaum, L., Wilson, P., Janz, S., Papavasiliou, F. N., Casellas, R. (2007). Regulation of AID expression in the immune response. J. Exp. Med. 204:1145-1156
27. DeFrancesco, L. (2008). Dynavax trial halted. Nat. Biotechnol. 26:484.
28. Dienz, O., Eaton, S. M., Bond, J.P., Neveu, W., Moquin, D., Noubade, R., Briso, E. M., Charland, C., Leonard, W. J., Ciliberto, G., Teuscher, C., Haynes, L., Rincon, M. (2009). The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206:69-78.
29. Dullaers, M., Li, D., Xue, Y., Ni, L., Gayet, I., Morita, R., Ueno, H., Palucka, K. A., Banchereau, J., Oh, S. (2009). A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 30:120-129
30. Fagarasan, S., Honjo, T. (2003). Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol. 3:63-72.
31. Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., Honjo, T. (2001). In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413:639-643
32. Fazilleau, N., Mark, L., McHeyzer-Williams, L. J., McHeyzer-Williams, M. G. (2009). Follicular helper T cells: lineage and location. Immunity 30:324-335
33. Gardby, E., Lycke, N. Y. (2000). CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches. Eur. J. Immunol. 30:1861-1871
34. Gardby, E., Wrammert, J., Schon, K., Ekman, L., Leanderson, T., Lycke, N. (2003). Strong Differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant. J. Immunol. 170:55-63.
35. Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W., Ferris, D. G., Steben, M., Bryan, J., Taddeo, F. J., Railkar, R., Esser, M. T., Sings, H. L., Nelson, M., Boslego, J., Sattler, C., Barr, E., Koutsky, L. A. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356:1928-1943 (Pubitemid 46740303)
36. Geha, R. S., Jabara, H. H., Brodeur, S. R. (2003). The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3:721-732
37. Gluck, R., Mischler, R., Durrer, P., Furer, E., Lang, A. B., Herzog, C., Cryz, Jr., S.J. (2000). Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J. Infect. Dis. 181:1129-1132
38. Ha, S. A., Tsuji, M., Suzuki, K., Meek, B., Yasuda, N., Kaisho, T., Fagarasan, S. (2006). Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203:2541-2550
39. Harriman, W., Volk, H., Defranoux, N., Wabl, M. (1993). Immunoglobulin class switch recombination. Annu. Rev. Immunol. 11:361-384
40. Hayakawa, K., Hardy, R. R., Stall, A. M., Herzenberg, L. A., Herzenberg, L. A. (1986). Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16:1313-1316
41. He, B., Xu, W., Santini, P. A., Polydorides, A. D., Chiu, A., Estrella, J., Shan, M., Chadburn, A., Villanacci, V., Plebani, A., Knowles, D. M., Rescigno, M., Cerutti, A. (2007). Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26:812-826
42. Heusser, C. H., Anderson, C. L., Grey, H. M. (1977). Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145:1316-1327
43. Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., Bachmann, M. F. (2007). TLR9 signaling in B cells determines class switch recombination to IgG2a. J. Immunol. 178:2415-2420
44. Jennings, G. T., Bachmann, M. F. (2007). Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines. Curr. Mol. Med. 7:143-155
45. Jennings, G. T., Bachmann, M. F. 2008. The coming of age of virus-like particle vaccines. Biol. Chem. 389:521-536
46. Kaetzel, C. S., Robinson, J. K., Chintalacharuvu, K. R., Vaerman, J. P., Lamm, M. E. (1991). The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc. Natl. Acad. Sci. USA 88:8796-8800
47. Kaminski, D. A., Stavnezer, J. (2006). Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J. Immunol. 177:6025-6029.
48. Kang, S.-M., Guo, L., Yao, Q., Skountzou, I., Compans, R. W. (2004). Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J. Virol. 78:9624-9632.
49. Kato, A., Truong-Tran, A. Q., Scott, A. L., Matsumoto, K., Schleimer, R. P. (2006). Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-betadependent mechanism. J. Immunol. 177:7164-7172
50. Katsenelson, N., Kanswal, S., Puig, M., Mostowski, H., Verthelyi, D., Akkoyunlu, M. 2007. Synthetic CpG oligodeoxynucleotides augment BAFF-and APRIL-mediated immunoglobulin secretion. Eur. J. Immunol. 37:1785-1795
51. Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., Pallansch, M. A. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635.
52. Kipps, T.J., Parham, P., Punt, J., Herzenberg, L. A. (1985). Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161:1-17.
53. Kiyono, H., Fukuyama, S. (2004). NALT-versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4:699-710.
54. Klaus, G.G., Pepys, M. B., Kitajima, K., Askonas, B. A. (1979). Activation of mouse complement by different classes of mouse antibody. Immunology 38:687-695
55. Kozlowski, P. A., Williams, S. B., Lynch, R. M. Flanigan, T. P., Patterson, R. R., Cu-Uvin, S., Neutra, M. R. (2002). Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle. J. Immunol. 169:566-574.
56. Kroese, F. G., Butcher, E. C., Stall, A. M., Lalor, P. A., Adams, S., Herzenberg, L. A. (1989). Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int. Immunol. 1:75-84.
57. Kuchen, S., Robbins, R., Sims, G. P., Sheng, C., Phillips, T. M., Lipsky, P. E., Ettinger, R. (2007). Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J. Immunol. 179:5886-5896
58. Lamm, M. E. (1997). Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51:311-340
59. Lawler, S., Candia, A. F., Ebner, R., Shum, L., Lopez, A. R., Moses, H. L., Wright, C. V., Derynck, R. (1994). The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1. Development 120:165-175
60. Levine, M. M. (2003). Can needle-free administration of vaccines become the norm in global immunization? Nat Med. 9:99-103.
61. Levine, M. M., Dougan, G. (1998). Optimism over vaccines administered via mucosal surfaces. Lancet 351:1375-1376
62. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K., Flavell, R. A. (2006). Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24:99-146.
63. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., Cerutti, A. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-829
64. Lundgren, M., Persson, U., Larsson, P., Magnusson, C., Smith, C. I., Hammarstrom, L., Severinson, E. 1989. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur. J. Immunol. 19:1311-1315 (Pubitemid 19196912)
65. Mackay, F., Schneider, P. (2009). Cracking the BAFF code. Nat. Rev. Immunol. 9:491-502.
66. MacLennan, I. C. (1994). Germinal centers. Annu Rev Immunol. 12:117-139
67. Macpherson, A. J., Gatto, D., Sainsbury, E., Harriman, G. R., Hengartner, H., Zinkernagel, R. M. (2000). A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 288:2222-2226
68. Macpherson, A. J., McCoy, K. D., Johansen, F. E., Brandtzaeg, P. (2008). The immune geography of IgA induction and function. Mucosal Immunol. 1:11-22.
69. McHeyzer-Williams, M. G., Ahmed, R. (1999). B cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 11:172-179
70. Melnick, J. L. (1996). Current status of poliovirus infections. Clin Microbiol Rev. 9:293-300.
71. Mond, J. J., Lees, A., Snapper, C. M. (1995). T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692
72. Mora, J.R., von Andrian, U. H. (2008). Differentiation and homing of IgA-secreting cells. Mucosal Immunol. 1:96-109.
73. Muramatsu, M., Nagaoka, H., Shinkura, R., Begum, N.A., Honjo, T. (2007). Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol. 94:1-36.
74. Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., Steffen, R. (2004). Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350:896-903.
75. Neutra, M. R., Kozlowski, P. A. (2006). Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6:148-158
76. Nimmerjahn, F., Ravetch, J. V. (2006). Fcgamma receptors: old friends and new family members. Immunity 24:19-28.
77. Odegard, V. H., Schatz, D. G. (2006). Targeting of somatic hypermutation. Nat. Rev. Immunol. 6:573-583
78. Ogra, P. L., Faden, H., Welliver, R. C. (2001). Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14:430-445
79. Ozaki, K., Spolski, R., Feng, C. G., Qi, C. F., Cheng, J., Sher, A., Morse, 3rd, H. C., Liu, C., Schwartzberg, P. L., Leonard, W. J. (2002). A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630-1634
80. Park, S. R., Lee, J. H., Kim, P. H. (2001). Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur. J. Immunol. 31:1706-1715
81. Pene, J., Gauchat, J.-F., Lecart, S., Drouet, E., Guglielmi, P., Boulay, V., Delwail, A., Foster, D., Lecron, J.-C., Yssel, H. (2004). Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154-5157
82. Pulendran, B. (2009). Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9:741-747
83. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Koehler, G., Kopf, M. (1994). The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563
84. Rharbaoui, F., Drabner, B., Borsutzky, S., Winckler, U., Morr, M., Ensoli, B., Muhlradt, P. F., Guzman, C. A. (2002). The mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant. Eur. J. Immunol. 32:2857-2865
85. Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro, G. M., Nespoli, A., Viale, G., Allavena, P., Rescigno, M. (2005). Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6:50-114
86. Rudin, A., Riise, G. C., Holmgren, J. (1999). Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun. 67:2884-2890
87. Sakurai, D., Hase, H., Kanno, Y., Kojima, H.., Okumura, K., Kobata, T. (2007). TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 109:2961-2967
88. Sangster, M. Y., Riberdy, J. M., Gonzalez, M., Topham, D. J., Baumgarth, N., Doherty, P. C. (2003). An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198:1011-1021
89. Sato, A., Hashiguchi, M., Toda, E., Iwasaki, A., Hachimura, S., Kaminogawa, S. (2003). CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J. Immunol. 171:3684-3690
90. Schmitt, N., Morita, R., Bourdery, L., Bentebibel, S. E., Zurawski, S. M., Banchereau, J., Ueno, H. (2009). Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31:158-169
91. Shang, L., Fukata, M., Thirunarayanan, N., Martin, A. P., Arnaboldi, P., Maussang, D., Berin, C., Unkeless, J. C., Mayer, L., Abreu, M. T., Lira, S. A. (2008). Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135:529-538
92. Shapiro-Shelef, M., Calame, K. (2005). Regulation of plasma-cell development. Nat. Rev. Immunol. 5:230-242
93. Shimizu, A., Takahashi, N., Yaoita, Y.,. Honjo, T. (1982). Organization of the constantregion gene family of the mouse immunoglobulin heavy chain. Cell 28:499-506.
94. Stavnezer, J., Guikema, J. E., Schrader, C. E. (2008). Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26:261-292
95. Sung, J. J., Lik-Yuen, H. (2006). HBV-ISS (Dynavax). Curr. Opin. Mol. Ther. 8:150-155
96. Tezuka, H., Abe, Y., Iwata, M., Takeuchi, H. Ishikawa, H., Matsushita, M., Shiohara, T., Akira, S., Ohteki, T. (2007). Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448:929-933
97. Treml, L. S., Carlesso, G., Hoek, K. L., Stadanlick, J. E., Kambayashi, T., Bram, R. J., Cancro, M. P., Khan, W. N. (2007). TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J. Immunol. 178:7531-7539.
98. Trinchieri, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146
99. van Duin, D., Medzhitov, R., Shaw, A. C. (2006). Triggering TLR signaling in vaccination. Trends Immunol. 27:49-55.
100. van Egmond, M., Damen, C. A., van Spriel, A. B., Vidarsson, G., van Garderen, E., van de Winkel, J. G. (2001). IgA and the IgA Fc receptor. Trends Immunol. 22:205-211
101. van Ginkel, F. W., Jackson, R. J., Yuki, Y., McGhee, J. R. (2000). Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165:4778-4782
102. van Ginkel, F. W., Wahl, S. M., Kearney, J. F., Kweon, M. N., Fujihashi, K., Burrows, P. D., Kiyono, H., McGhee, J. R. (1999). Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice. J. Immunol. 163:1951-1957
103. von Bulow, G. U., van Deursen, J. M., Bram, R. J. (2001). Regulation of the T-independent humoral response by TACI. Immunity 14:573-582
104. Xu, W., He, B., Chiu, A. Chadburn, A., Shan, M., Buldys, M., Ding, A., Knowles, D. M., Santini, P. A., Cerutti, A. (2007). Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8:294-303.
105. Yan, M., Wang, H., Chan, B., Roose-Girma, M., Erickson, S., Baker, T., Tumas, D., Grewal, I. S., Dixit, V. M. (2001). Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:638-643
106. Zinkernagel, R. M., Hengartner, H. (2004). On immunity against infections and vaccines: credo 2004. Scand. J. Immunol. 60:9-13.